Oncolib 100mg Tablet is an anticancer oral targeted prescription medication consisting of palbociclib (100 mg in each film-coated tablet), marketed/manufactured in Pakistan by ONCOLIB 100MG TABLET Oncogen Pharma.
It is usually prescribed for use in treating patients suffering from ONCOLIB 100 MG TABLET IN PAKISTAN hormone receptor positive (HR+), HER2 negative advanced or metastatic breast cancer.
Mechanism: Inhibits activity of cyclin-dependent kinases 4 and 6 (CDK4/6) which assist cancer cells in their division and thus helps stop tumor growth.
Use: Usually given in combination with hormonal/endocrine therapy (for example, in combination with an aromatase inhibitor or fulvestrant) in patients suffering from HR-positive, HER2-negative locally advanced or metastatic breast cancer. (Also approved in other combinations based on clinical protocols and the nature of the disease).
Form/Strength: 100 mg film-coated oral tablet (there are different forms available such as 75 mg, 125 mg; for example, in Pakistan the form usually stated in packs of 7 tablets).
Administration: Take orally once daily at about the same time, with or without food. Take whole tablets without crushing, splitting, chewing or taking damaged ones.
Regimen/Schedule: Palbociclib regimen usually consists of 28 days cycle (21 days of therapy followed by 7 days without) and a 100 mg dose as part of reduced dose; always
WhatsApp us